Bristol-Myers Squibb Co
JPMorgan’s top biotech and pharma picks for the second half
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]
Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]
Read More
Stocks making the biggest moves midday: Tesla, BioNTech, DraftKings, Steel Dynamics and more
Check out the companies making headlines in midday trading. Tesla — Shares of the electric vehicle company dropped 3% after sales in May in declined in several European markets. Reuters reported that Tesla suffered weaker sales in Sweden, France, Spain, Denmark and the Netherlands, but improved in Norway, boosted by the revamped Model Y. Advertising […]
Read More
Stocks making the biggest premarket moves: Cleveland-Cliffs, Nucor, Moderna, Tesla and more
Check out the companies making the biggest moves in premarket trading: Steel stocks — Shares of steel companies soared after President Donald Trump doubled tariffs on the metal to 50% from 25%. Cleveland-Cliffs rallied 26%, while Nucor added nearly 11% and Steel Dynamics rose 10%. BioNTech — The Germany-based biotech stock jumped 11.3% after Bristol […]
Read More
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
Trump’s plan to slash drug prices may struggle to get off the ground – here’s what to know
President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S. […]
Read More
Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more
Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, […]
Read More
These 6 portfolio names pledged big U.S. investments since Trump took office again
Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back […]
Read More
Stocks making the biggest moves midday: AppLovin, Carvana, MercadoLibre, Crocs and more
Check out the companies making headlines in midday trading. AppLovin — The mobile ad tech company jumped 12% after first-quarter results that beat analyst expectations. AppLovin also announced it would sell its mobile gaming business in a $400 million deal. Carvana — Shares jumped more than 11% after the online used car marketplace posted better-than-expected […]
Read More
Stocks making the biggest moves premarket: Shopify, AppLovin, Peloton, Tapestry and more
Check out the companies making headlines in premarket trading. Shopify — Shares of the commerce technology platform dove 8.7% even after first-quarter revenue came in at $2.36 billion, beating the FactSet consensus estimate of $2.33 billion. Shopify had risen 20% over the past month, and its full year guidance set operating expenses at 39%-40% of […]
Read More